Alembic receives FDA OK for generic Pradaxa
Dabigatran Etexilate capsules are indicated for prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery.
The Food and Drug Administration has granted Alembic permission for Dabigatran Etexilate Capsules, 110 mg, which is the generic of Boehringer Ingelheim’s Pradaxa.
[Read more: Alembic gets FDA tentative OK for generic Bosulif]
Dabigatran Etexilate capsules 110 mg are indicated for prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery.
[Read more: Alembic intros generic Perforomist]